107 results
Page 4 of 6
8-K
EX-10.1
10xa5
8 Nov 17
DelMar Pharmaceuticals Appoints Saiid Zarrabian as Interim Chief Executive Officer
12:00am
8-K
EX-10.2
p4bhqxvus
8 Nov 17
DelMar Pharmaceuticals Appoints Saiid Zarrabian as Interim Chief Executive Officer
12:00am
8-K
EX-10.1
e9rx8t dqz5ir1i90
21 Sep 17
Delmar Pharmaceuticals Announces $10 Million Registered Direct Offering Priced At-the-market
12:00am
8-K
EX-10.2
vjh2ofn
21 Sep 17
Delmar Pharmaceuticals Announces $10 Million Registered Direct Offering Priced At-the-market
12:00am
8-K
EX-10.2
k8yqqp9 0yskhdt
13 Apr 17
Delmar Pharmaceuticals Announcesproposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-10.3
8oa2bmi
13 Apr 17
Delmar Pharmaceuticals Announcesproposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-10.1
4xodzh bjd
13 Apr 17
Delmar Pharmaceuticals Announcesproposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-10.4
zf3kvs9e
13 Apr 17
Delmar Pharmaceuticals Announcesproposed Public Offering of Common Stock and Warrants
12:00am
8-K
EX-10.2
qykgz
5 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
nzx2h68xztgu ok
5 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
45uygxex
5 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
x1v5ke32
31 Dec 15
Entry into a Material Definitive Agreement
12:00am